Fund Holdings — TFG Asset Management GP Ltd

Total Portfolio Value:
$614.32M
Total Bought:
$141.85M
Total Sold:
$38.48M
Net Transaction:
+$103.37M
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
UiPath, Inc.CL A(PATH)25,207,62830,950,000+5,742,372$279.80M$336.43M54.76%+$56.62M
Kolibri Global Energy Inc.(KGEI)6,834,5046,834,5040$37.52M$33.85M5.51%-$3.68M
Autolus Therapeutics plcADS(AUTL)9,500,0009,500,0000$13.11M$15.20M2.47%+$2.09M
Lyft, Inc.CL A(LYFT)1,000,0001,000,0000$13.30M$14.61M2.38%+$1.31M
Definium Therapeutics, Inc.(DFTX)199,994286,990+86,996$3.78M$13.50M2.20%+$9.72M
Workiva Inc.CL A(WK)250,000250,0000$14.91M$12.13M1.97%-$2.78M
Sprinklr, Inc.CL A(CXM)2,200,0002,200,0000$13.20M$11.35M1.85%-$1.85M
MBX Biosciences, Inc.(MBX)145,480203,543+58,063$4.34M$11.24M1.83%+$6.89M
Alkami Technology, Inc.(ALKT)0600,284+600,284$0$10.88M1.77%+$10.88M
Celldex Therapeutics, Inc.(CLDX)312,316290,441-21,875$9.91M$10.81M1.76%+$900.6K
Relay Therapeutics, Inc.(RLAY)181,543570,311+388,768$1.81M$10.67M1.74%+$8.86M
Arrowhead Pharmaceuticals, Inc.(ARWR)127,198130,484+3,286$7.98M$10.64M1.73%+$2.66M
Pharvaris N V
COM
221,611295,627+74,016$6.26M$10.22M1.66%+$3.96M
Alkermes plcSHS(ALKS)159,791189,979+30,188$5.65M$9.95M1.62%+$4.30M
Immunovant, Inc.(IMVT)218,507255,934+37,427$5.43M$9.86M1.61%+$4.43M
Silence Therapeutics plcADS(SLN)630,161764,256+134,095$3.32M$8.39M1.37%+$5.07M
Dyne Therapeutics, Inc.(DYN)258,132356,657+98,525$4.68M$7.92M1.29%+$3.24M
Ionis Pharmaceuticals, Inc.(IONS)41,76497,173+55,409$3.14M$7.70M1.25%+$4.57M
Agios Pharmaceuticals, Inc.(AGIO)164,839205,579+40,740$5.58M$7.63M1.24%+$2.05M
Harmony Biosciences Holdings, Inc.(HRMY)119,340201,036+81,696$3.34M$7.32M1.19%+$3.98M
Krystal Biotech, Inc.(KRYS)19,66819,6680$5.08M$7.31M1.19%+$2.23M
Annexon, Inc.(ANNX)1,292,4551,242,455-50,000$7.16M$7.09M1.15%-$65.8K
Celcuity Inc.(CELC)064,110+64,110$0$6.71M1.09%+$6.71M
Warner Bros Discovery IncCOM SER A923,725250,000-673,725$25.37M$6.67M1.08%-$18.70M
Nektar Therapeutics(NKTR)103,03786,996-16,041$7.41M$6.07M0.99%-$1.34M
Amylyx Pharmaceuticals, Inc.(AMLX)317,877297,926-19,951$4.42M$5.35M0.87%+$932.3K
Acadia Pharmaceuticals Inc144,620167,875+23,255$3.22M$4.25M0.69%+$1.03M
Cue Biopharma, Inc.(CUE)093,819+93,819$0$2.96M0.48%+$2.96M
Snowflake Inc.(SNOW)10,00010,0000$1.51M$2.54M0.41%+$1.04M
Aclaris Therapeutics, Inc.(ACRS)0400,000+400,000$0$2.12M0.34%+$2.12M
Tectonic Therapeutic, Inc.(TECX)37,58846,516+8,928$1.16M$1.60M0.26%+$437.1K
Monte Rosa Therapeutics, Inc.(GLUE)056,052+56,052$0$1.36M0.22%+$1.36M
Aardvark Therapeutics Inc316,6210-316,621$1.19M$0—-$1.19M
Axsome Therapeutics, Inc.(AXSM)20,0590-20,059$3.39M$0—-$3.39M
Karyopharm Therapeutics Inc.(KPTI)52,9840-52,984$295.1K$0—-$295.1K
MapLight Therapeutics, Inc.(MPLT)112,1150-112,115$2.28M$0—-$2.28M
Praxis Precision Medicines, Inc.(PRAX)15,9520-15,952$5.14M$0—-$5.14M
Soleno Therapeutics Inc102,1250-102,125$3.42M$0—-$3.42M
Ultragenyx Pharmaceutical Inc.(RARE)39,4730-39,473$827.0K$0—-$827.0K
Page 1 of 1
TFG Asset Management GP Ltd — 13F Holdings — Q2 2026 | TickerTrail